Ginkgo Bioworks Holdings Inc (DNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DNA Annual Balance Sheets →
A period-by-period view of the balance sheet from Ginkgo Bioworks Holdings Inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent84.54
Marketable Securities, Total MA217.63
Cash & Short-term Investments301.00
Accounts receivable13.01
Other Receivables7.40
Other Current Assets0.00
Prepaid Expense And Other Assets Current17.36
Total Current Assets332.54
Equipment/Property/Plant Net354.77
Intangible Assets44.39
Long-term investments7.62
Disposal Group, Including Discontinued Operation, Assets, Noncurrent AS0.00
Other Assets, Noncurrent235.97
Total Assets990.05
Liabilities
Accounts Payable, Current AC9.58
Accrued Liabilities And Other Liabilities49.95
Other Liabilities, Current7.78
Discontinued Operation, Liabilities5.44
Total Current Liabilities72.74
Total Long-term Debt0.00
Other liabilities, Noncurrent497.02
Contract With Customer Liability Current14.91
Contract With Customer Liability Noncurrent77.90
Operating Lease Liability Noncurrent410.70
Total Liabilities569.76
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock6,698.95
Retained Earnings / Accumulated Deficit-6,279.62
Accumulated Other Comprehensive Income0.95
Other Equity0.95
Common Stockholder's Equity420.28
Total Stockholder's Equity420.28
Liabilities & Stockholder's Equity990.05
4 historic quarters locked

Sign in to unlock the full Ginkgo Bioworks Holdings Inc balance sheet history.

About Ginkgo Bioworks Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 6, 2026
  • Source: dna-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-054298

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.